1191908-49-2

Upstream product

• 1191908-48-1 2-{1-[3-(methylsulfonyl)phenyl]ethyl}-1H-isoindole-1,3(2H)-dione 

Downstream Products

• 1191908-07-2 5-chloro-2-imino-1-(1-(3-(methylsulfonyl)phenyl)ethyl)-1,2-dihydropyridine-3-carboxamide monohydrochloride 
• 1611473-58-5 8-bromo-N-(1-(3-(methylsulfonyl)phenyl)ethyl)-1,6-naphthyridine-2-carboxamide 
• 1611472-32-2 8-(4-chlorophenyl)-N-(1-(3-(methylsulfonyl)phenyl)ethyl)-1,6-naphthyridine-2-carboxamide 

Relevant academic research and scientific papers

SPIROUREA DERIVATIVES

The invention relates to compounds of Formula (I) wherein X1, X2, X3, Y, R1, R2A, R2B, R3, and R4 are as described in the description; to their preparation, to pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing one or more compounds of Formula (I), and to the use of such compounds as medicaments, especially as Kv7 openers.

IMINOPYRIDINE DERIVATIVE AND USE THEREOF

The present invention aims to provide a compound having a superior selective α1D adrenergic receptor antagonistic action and useful as an agent for the prophylaxis or treatment of a lower urinary tract disease and the like.The present invention provides a compound represented by the formula (I) wherein each symbol is as defined in the specification, or a salt thereof.The present invention aims to provide a compound having a superior selective ± 1D adrenergic receptor antagonistic action and useful as an agent for the prophylaxis or treatment of a lower urinary tract disease and the like. The present invention provides a compound represented by the formula (I) wherein each symbol is as defined in the specification, or a salt thereof.